Illustrative image (Photo: VNA) Hanoi (VNA) – Deputy Health Minister Tran Van Thuan has said his ministry supports the expansion ofareas eligible for the third phase of clinical trials of Nanocovax, a product of Nanogen PharmaceuticalBiotechnology JSC based on recombinant DNA/protein technology.
The work must ensure safety and feasibility,he said.
Earlier, the vaccine underwent thefirst-phase test from December 18, 2020, the second phase from February 26,2021 and the third phase from June 11, 2021.
According to the approved plan, thethird-phase trials aim to assess the vaccine’s efficacy and is carried out inmany centres worldwide with 13,000 volunteers.
Earlier, Deputy Prime Minister Pham MinhChinh asked the Health Minister to direct the use and licensing of Nanocovax withless administrative procedures and in line with regulations.
Ata nationwide teleconference between the Government and businesses, ministries,agencies and localities, Chinh underlined three major contents of vaccinestrategy, including importing as many as vaccines possible at the earliest.
Amidthe global shortage of vaccines, the country strives to access them viadifferent channels, including stepping up vaccine diplomacy, he said./.
